Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...

Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of new partnerships or products, namely the MiSeq i100 benchtop sequencer.

the Chinese government’s announcement prohibits Illumina’s machines from being imported from the U.S. It does not specify products and reagents — the chemicals used in the gene sequencing ...

11 analysts have expressed a variety of opinions on Illumina ILMN over the past quarter, offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments ...

Illumina stock recovered early losses Tuesday after China signaled it would ban the company from importing its gene-mapping products. While in positive territory ahead of Tuesday's market close ...

SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina (ILMN.O), opens new tab ...

Here are the biggest headlines of the day in the latest Market Minute. Illumina (ILMN) shares have recouped their losses. The stock had fallen after China banned it from exporting its gene ...

China’s Ministry of Commerce said it would ban Illumina, a San Diego company, from importing its gene-mapping products in China. Illumina is the world’s leading producer of gene-sequencing ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

In its fourth quarter 2024 investor letter, Brown Advisors Global Leaders Strategy emphasized stocks such as Illumina, Inc. (NASDAQ:ILMN). Illumina, Inc. (NASDAQ:ILMN) offers sequencing- and array ...